|
OMIM |
Link |
Information gain |
01 |
|
EKD1
|
[NCBI]
|
0.00613959
|
|
|
IBGC1
|
[NCBI]
|
0.00338726
|
|
|
basal ganglia calcification, idiopathic, 2
|
[NCBI]
|
0.00194785
|
|
|
PSNP2
|
[NCBI]
|
0.00194785
|
|
|
GTS
|
[NCBI]
|
0.00181329
|
|
|
CHAT
|
[NCBI]
|
0.00137533
|
|
|
angiomatosis, diffuse corticomeningeal, of divry and van bogaert
|
[NCBI]
|
0.0012789
|
|
|
pallidopyramidal syndrome
|
[NCBI]
|
0.000968636
|
|
|
PD
|
[NCBI]
|
0.000856246
|
|
|
folic acid, transport defect involving
|
[NCBI]
|
0.000776494
|
|
|
DYT2
|
[NCBI]
|
0.000776494
|
|
|
EKD2
|
[NCBI]
|
0.000676108
|
|
|
basal ganglia calcification, idiopathic, childhood-onset
|
[NCBI]
|
0.000676108
|
|
|
MYMY1
|
[NCBI]
|
0.000639279
|
|
|
CJD
|
[NCBI]
|
0.000612395
|
|
|
RA
|
[NCBI]
|
0.000382606
|
|
|
SLC6A3
|
[NCBI]
|
0.000339506
|
|
|
ACHE
|
[NCBI]
|
0.00032684
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
0.000306984
|
|
|
MAFD6
|
[NCBI]
|
0.000279555
|
|
|
FTD
|
[NCBI]
|
0.000253447
|
|
|
TH
|
[NCBI]
|
0.000190869
|
|
|
PSNP1
|
[NCBI]
|
0.000189498
|
|
|
SNDI
|
[NCBI]
|
0.000179286
|
|
|
AGS1
|
[NCBI]
|
0.000179286
|
|
|
craniosynostosis, calcification of basal ganglia, and facial dysmorphism
|
[NCBI]
|
0.000168195
|
|
|
NBIA1
|
[NCBI]
|
0.00016684
|
|
|
DYT1
|
[NCBI]
|
0.000143188
|
|
|
SLE
|
[NCBI]
|
0.000141723
|
|
|
CHAC
|
[NCBI]
|
0.000132406
|
|
|
cerebrocortical degeneration of infancy
|
[NCBI]
|
0.000128992
|
|
|
band heterotopia of brain
|
[NCBI]
|
0.000114242
|
|
|
SCA27
|
[NCBI]
|
0.000114242
|
|
|
NGFB
|
[NCBI]
|
0.000111996
|
|
|
HD
|
[NCBI]
|
0.000107363
|
|
|
choreoathetosis, hypothyroidism, and neonatal respiratory distress
|
[NCBI]
|
0.000104689
|
|
|
myoclonus and ataxia
|
[NCBI]
|
0.000104689
|
|
|
LNS
|
[NCBI]
|
0.000101173
|
|
|
dystonia, familial, with visual failure and striatal lucencies
|
[NCBI]
|
9.76048e-05
|
|
|
SCZD8
|
[NCBI]
|
9.76048e-05
|
|
|
gliosis, familial progressive subcortical
|
[NCBI]
|
9.19746e-05
|
|
|
aceruloplasminemia
|
[NCBI]
|
7.67622e-05
|
|
|
SCA10
|
[NCBI]
|
7.67622e-05
|
|
|
canavan disease
|
[NCBI]
|
7.39989e-05
|
|
|
DYT3
|
[NCBI]
|
7.14943e-05
|
|
|
GSD
|
[NCBI]
|
6.92052e-05
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
6.92052e-05
|
|
|
SCA17
|
[NCBI]
|
6.70983e-05
|
|
|
MLC
|
[NCBI]
|
6.3332e-05
|
|
|
alexander disease
|
[NCBI]
|
6.3332e-05
|
|
|
krabbe disease
|
[NCBI]
|
6.27475e-05
|
|
|
crigler-najjar syndrome
|
[NCBI]
|
6.16347e-05
|
|
|
DLB
|
[NCBI]
|
6.00418e-05
|
|
|
glutaric acidemia i
|
[NCBI]
|
6.00418e-05
|
|
|
FIH
|
[NCBI]
|
5.85416e-05
|
|
|
PARK2
|
[NCBI]
|
5.71245e-05
|
|
|
PNKD1
|
[NCBI]
|
5.57819e-05
|
|
|
MSS
|
[NCBI]
|
5.57819e-05
|
|
|
PPP1R1B
|
[NCBI]
|
5.36077e-05
|
|
|
AD
|
[NCBI]
|
5.187e-05
|
|
|
PFIC1
|
[NCBI]
|
5.10296e-05
|
|
|
VEGF
|
[NCBI]
|
5.08823e-05
|
|
|
camp-regulated phosphoprotein, 19-kd
|
[NCBI]
|
4.79394e-05
|
|
|
ARX
|
[NCBI]
|
4.78253e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
4.25203e-05
|
|
|
CSA
|
[NCBI]
|
4.20778e-05
|
|
|
PDYN
|
[NCBI]
|
4.18566e-05
|
|
|
EGF
|
[NCBI]
|
4.18545e-05
|
|
|
GFAP
|
[NCBI]
|
4.11423e-05
|
|
|
camp-regulated phosphoprotein, 21-kd
|
[NCBI]
|
3.7965e-05
|
|
|
RASGRP2
|
[NCBI]
|
3.7965e-05
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
3.61823e-05
|
|
|
FCMD
|
[NCBI]
|
3.61823e-05
|
|
|
SLC18A2
|
[NCBI]
|
3.47812e-05
|
|
|
ALS1
|
[NCBI]
|
3.39888e-05
|
|
|
TD1
|
[NCBI]
|
3.19969e-05
|
|
|
RASGRP1
|
[NCBI]
|
3.17681e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
2.87671e-05
|
|
|
GNAL
|
[NCBI]
|
2.85168e-05
|
|
|
FGF14
|
[NCBI]
|
2.73202e-05
|
|
|
LS
|
[NCBI]
|
2.58755e-05
|
|
|
NRP2
|
[NCBI]
|
2.54038e-05
|
|
|
FOXP2
|
[NCBI]
|
2.46112e-05
|
|
|
PRNP
|
[NCBI]
|
2.44286e-05
|
|
|
PSPN
|
[NCBI]
|
2.3899e-05
|
|
|
MDD
|
[NCBI]
|
2.37914e-05
|
|
|
DYT1
|
[NCBI]
|
2.32527e-05
|
|
|
EIF2B5
|
[NCBI]
|
2.32527e-05
|
|
|
DRD3
|
[NCBI]
|
2.26611e-05
|
|
|
SPR
|
[NCBI]
|
2.21158e-05
|
|
|
SEMA3F
|
[NCBI]
|
2.21158e-05
|
|
|
fabry disease
|
[NCBI]
|
2.17884e-05
|
|
|
PPP3CA
|
[NCBI]
|
2.16102e-05
|
|
|
NKX2-1
|
[NCBI]
|
2.1139e-05
|
|
|
ATP7B
|
[NCBI]
|
2.1139e-05
|
|
|
NPY
|
[NCBI]
|
2.08487e-05
|
|
|
BCNS
|
[NCBI]
|
2.04342e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
1.99209e-05
|
|
|
PANK2
|
[NCBI]
|
1.98921e-05
|
|
|
NGFR
|
[NCBI]
|
1.98523e-05
|
|
|
NRP1
|
[NCBI]
|
1.91712e-05
|
|
|
NRTN
|
[NCBI]
|
1.85191e-05
|
|
|
TAF1
|
[NCBI]
|
1.79243e-05
|
|
|
BCHE
|
[NCBI]
|
1.77204e-05
|
|
|
PMD
|
[NCBI]
|
1.7352e-05
|
|
|
GRIN1
|
[NCBI]
|
1.66329e-05
|
|
|
DRD2
|
[NCBI]
|
1.6402e-05
|
|
|
KSS
|
[NCBI]
|
1.51462e-05
|
|
|
BDNF
|
[NCBI]
|
1.44152e-05
|
|
|
SEMA3A
|
[NCBI]
|
1.41234e-05
|
|
|
ARF1
|
[NCBI]
|
1.41234e-05
|
|
|
GDNF
|
[NCBI]
|
1.38898e-05
|
|
|
CCK
|
[NCBI]
|
1.25913e-05
|
|
|
DMD
|
[NCBI]
|
1.14202e-05
|
|
|
PRL
|
[NCBI]
|
1.05999e-05
|
|
|
SLC11A2
|
[NCBI]
|
1.01204e-05
|
|
|
HPRT1
|
[NCBI]
|
8.71704e-06
|
|
|
MJD
|
[NCBI]
|
8.68446e-06
|
|
|
MAPT
|
[NCBI]
|
8.5878e-06
|
|
|
FAAH
|
[NCBI]
|
5.60973e-06
|
|
|
MBP
|
[NCBI]
|
5.31079e-06
|
|
|
CP
|
[NCBI]
|
4.12997e-06
|
|
|
CDK5
|
[NCBI]
|
3.11982e-06
|
|
|
LRP1
|
[NCBI]
|
2.80167e-06
|
|
|
PNMT
|
[NCBI]
|
2.49897e-06
|
|
|
VIP
|
[NCBI]
|
1.002e-06
|
|
|
APOE
|
[NCBI]
|
7.98291e-07
|
|
|
AFP
|
[NCBI]
|
1.21016e-07
|
|
|
GAPDH
|
[NCBI]
|
9.22356e-08
|
|
|
ADCYAP1
|
[NCBI]
|
5.45359e-08
|
|
|
SPP1
|
[NCBI]
|
4.09563e-08
|
|
|
MPO
|
[NCBI]
|
1.61487e-08
|
|
|
CRH
|
[NCBI]
|
1.51551e-08
|
|